113 related articles for article (PubMed ID: 2285001)
21. Naftidrofuryl for dementia.
Lu D; Song H; Hao Z; Wu T; McCleery J
Cochrane Database Syst Rev; 2011 Dec; (12):CD002955. PubMed ID: 22161372
[TBL] [Abstract][Full Text] [Related]
22. Effects of naftidrofuryl on the time course of the regional cerebral blood flow in acute ischemic stroke.
Kobayashi S; Yamaguchi S; Katsube T; Okada K; Kitani M; Murao M; Tsunematsu T
Arzneimittelforschung; 1984; 34(11):1580-3. PubMed ID: 6543134
[TBL] [Abstract][Full Text] [Related]
23. Effects of naftidrofuryl in patients with intermittent claudication.
Karnik R; Valentin A; Stöllberger C; Slany J
Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
[TBL] [Abstract][Full Text] [Related]
24. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
D'Hooge D; Lehert P; Clement DL
Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
[TBL] [Abstract][Full Text] [Related]
25. Naftidrofuryl (Praxilene).
Drug Ther Bull; 1988 Apr; 26(7):25-7. PubMed ID: 3286179
[No Abstract] [Full Text] [Related]
26. [Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo].
Poser R; Hirche H
HNO; 1992 Oct; 40(10):396-9. PubMed ID: 1385372
[TBL] [Abstract][Full Text] [Related]
27. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
Adhoute G; Andreassian B; Boccalon H; Cloarec M; Di Maria G; Lefebvre O; Mondine P; Plagnol P; Pointel JP; Quancard X
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S75-80. PubMed ID: 1369725
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
Hirsch JL; Bensoussan JJ; Mosnier M; Lehert P
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
[TBL] [Abstract][Full Text] [Related]
29. [The efficacy of naftidrofuryl on unexpected autonomic symptoms following carpal tunnel surgery].
Chaise F; Guest M; Bellemère P; Friol JP; Gaisne E; Lehert P
Ann Chir Main Memb Super; 1994; 13(3):214-21. PubMed ID: 7524591
[TBL] [Abstract][Full Text] [Related]
30. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
Moody AP; al-Khaffaf HS; Lehert P; Harris PL; Charlesworth D
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S44-7. PubMed ID: 7517477
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
Testart J; Guidicelli H; Glanddier G; Mosnier M
Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):542-7. PubMed ID: 7864561
[TBL] [Abstract][Full Text] [Related]
33. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.
Spengel F; Brown TM; Poth J; Lehert P
Vasa; 1999 Aug; 28(3):207-12. PubMed ID: 10483329
[TBL] [Abstract][Full Text] [Related]
34. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
Klein M; Hirche H
Klin Monbl Augenheilkd; 1985 Sep; 187(3):195-201. PubMed ID: 3906248
[TBL] [Abstract][Full Text] [Related]
35. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
Rosas G; Cerdeyra C; Lucas MA; Parano JR; Villa JJ
Angiology; 1981 May; 32(5):291-7. PubMed ID: 7235299
[TBL] [Abstract][Full Text] [Related]
36. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
[TBL] [Abstract][Full Text] [Related]
37. The effect of Naftidrofuryl on ethanol-induced liver damage in chronic alcoholic patients.
Majumdar SK; Shaw GK; O'Gorman P; Thomson AD
Drug Alcohol Depend; 1982; 10(2-3):135-42. PubMed ID: 6131800
[TBL] [Abstract][Full Text] [Related]
38. From tinnitus to acute hepatitis: Drug-induced injury caused by use of naftidrofuryl for one year.
Ouizeman DJ; Fortier Beaulieu C; Patouraux S; Tran A; Piche T; Anty R
Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):e93-e94. PubMed ID: 31023552
[No Abstract] [Full Text] [Related]
39. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
[TBL] [Abstract][Full Text] [Related]
40. Naftidrofuryl for intermittent claudication: a double-blind controlled trial.
Ruckley CV; Callam MJ; Ferrington CM; Prescott RJ
Br Med J; 1978 Mar; 1(6113):622. PubMed ID: 343869
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
